Skinvisible (SKVI) Interest Expenses (2010 - 2026)
Skinvisible's (SKVI) quarterly Interest Expenses came in at $142716.0 in Q2 2026, little changed year-over-year from $142720.0 in Q2 2025, and up 1.04% quarter-over-quarter from $141246.0 in Q1 2026.
Analysis
Skinvisible (SKVI) Interest Expenses (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Interest Expenses across 17 years of filings, most recently posting $142716.0 for Q2 2026.
- In Q2 2026, Interest Expenses changed 0.0% year-over-year to $142716.0; the TTM figure through Jun 2026 stood at $572338.0 (down 7.73% YoY), while the FY2025 annual figure was $572249.0, down 14.52% from the prior year.
- Interest Expenses came in at $142716.0 for Q2 2026 at Skinvisible, up from $141246.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.4 million in Q1 2023 to a low of $141153.0 in Q1 2025.
- Average Interest Expenses over 5 years is $254757.4, with a median of $167387.5 recorded in 2023.
- Year-over-year, Interest Expenses jumped 379.04% in 2023 and plunged 87.95% in 2024.
- Over 5 years, Interest Expenses stood at $291177.0 in 2022, then tumbled by 42.56% to $167253.0 in 2023, then climbed by 0.84% to $168663.0 in 2024, then slipped by 14.51% to $144188.0 in 2025, then slipped by 1.02% to $142716.0 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $142716.0 in Q2 2026, $141246.0 in Q1 2026, and $144188.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 23.78 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 2.90 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 142,716.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142,716.00 |
| Mar 31, 2026 | 141,246.00 |
| Dec 31, 2025 | 144,188.00 |
| Sep 30, 2025 | 144,188.00 |
| Jun 30, 2025 | 142,720.00 |
| Mar 31, 2025 | 141,153.00 |
| Dec 31, 2024 | 168,663.00 |
| Sep 30, 2024 | 167,757.00 |
| Jun 30, 2024 | 166,610.00 |
| Mar 31, 2024 | 167,188.00 |
| Dec 31, 2023 | 167,253.00 |
| Sep 30, 2023 | 174,408.00 |
| Jun 30, 2023 | 167,522.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 291,177.00 |
| Sep 30, 2022 | 291,178.00 |
| Jun 30, 2022 | 290,945.00 |
| Mar 31, 2022 | 289,569.00 |
| Dec 31, 2021 | 609,200.00 |
| Sep 30, 2021 | 294,216.00 |